Pfizer's stock drops after drug giant lowers its revenue forecast
The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year.
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
BTC
ETH
USDT
USDC
XRP
SOL
TRX
FIGR_HELOC
HYPE
DOGE
USDS
RAIN
LEO
ZEC
3153 articles about stocks
The pharmaceutical company updated its sales guidance for 2025, saying it now expects $62 billion in revenue for the year.
Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8)
Shares saw their first record close since December 2024, helping support the continued reign of the "Magnificent Seven."
DBV Technologies stock soars after positive Phase 3 trial results
Investors can expect asset write-downs and new plans from auto makers that leaned a little too hard into the trend. Curiously, that shouldn't be a headwind...
E.W. Scripps stock falls after board rejects Sinclair's $7 per share offer
Google's new deal could serve as a blueprint for the energy industry.
Growth may mellow out, but the long-term prospects remain strong.
Renowned TV host Jim Cramer issued a "Sell" rating on a prominent AI infrastructure stock that has been under pressure in recent weeks, despite several bul...